Linc-ROR also showed a trend of increasing expression in patients with more advanced clinical phases of ovarian cancer (P<0.01), while patients with lymph node metastases had higher linc-ROR expression than those without (P<0.01). This evidence concerns the gene LINC-ROR and ovarian carcinoma.